Literature DB >> 10220484

Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells.

P A Münzel1, S Schmohl, H Heel, K Kälberer, B S Bock-Hennig, K W Bock.   

Abstract

Human colon carcinoma Caco-2 cells were used to study the induction of UDP glucuronosyltransferase (UGT) isoforms UGT1A6, UGT1A9, and UGT2B7 by aryl hydrocarbon receptor agonists and by antioxidant-type inducers with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and t-butylhydroquinone (TBHQ), respectively. Early- (PF11) and late-passage clones (TC7) of Caco-2 cells, which show low and high constitutive UGT1A6 expression, respectively, were selected. The following results were obtained: 1) In Caco-2 cells UGT activity (4-methylumbelliferone as substrate) was significantly enhanced by 10 nM TCDD or 40 to 80 microM TBHQ and 2) duplex reverse-transcription-polymerase chain reaction analysis showed for the first time that the expression of human UGT1A6, UGT1A9, and UGT2B7 was enhanced by 40 to 80 microM TBHQ; both UGT1A6 and UGT1A9 were induced by 10 nM TCDD, whereas UGT2B7 was not induced by TCDD. The results suggest that at least two human UGTs (UGT1A6 and UGT1A9) are inducible by aryl hydrocarbon receptor agonists and even more isoforms (UGT1A6, UGT1A9, and UGT2B7) are inducible by antioxidant-type inducers in Caco-2 cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220484

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  14 in total

1.  Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells--potential role in carcinogen bioinactivation.

Authors:  A Galijatovic; Y Otake; U K Walle; T Walle
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  Cloning of UGT1A9 cDNA from liver tissues and its expression in CHL cells.

Authors:  X Li; Y N Yu; G J Zhu; Y L Qian
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

3.  Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers.

Authors:  Shelley A Gestl; Mitchell D Green; Debra A Shearer; Elizabeth Frauenhoffer; Thomas R Tephly; Judith Weisz
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

4.  Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2.

Authors:  David B Buckley; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2009-01-14       Impact factor: 3.922

Review 5.  Nicotine chemistry, metabolism, kinetics and biomarkers.

Authors:  Neal L Benowitz; Janne Hukkanen; Peyton Jacob
Journal:  Handb Exp Pharmacol       Date:  2009

6.  Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene.

Authors:  Federico Innocenti; Wanqing Liu; Donna Fackenthal; Jacqueline Ramírez; Peixian Chen; Xin Ye; Xiaolin Wu; Wei Zhang; Snezana Mirkov; Soma Das; Edwin Cook; Mark J Ratain
Journal:  Pharmacogenet Genomics       Date:  2008-08       Impact factor: 2.089

7.  Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells.

Authors:  A Galijatovic; U K Walle; T Walle
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

8.  Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes.

Authors:  Xin Li; Stacie Bratton; Anna Radominska-Pandya
Journal:  Drug Metab Pharmacokinet       Date:  2007-06       Impact factor: 3.614

9.  Implementation of a dynamic intestinal gut-on-a-chip barrier model for transport studies of lipophilic dioxin congeners.

Authors:  Kornphimol Kulthong; Loes Duivenvoorde; Barbara Z Mizera; Deborah Rijkers; Guillaume Ten Dam; Gerlof Oegema; Tomasz Puzyn; Hans Bouwmeester; Meike van der Zande
Journal:  RSC Adv       Date:  2018-09-19       Impact factor: 4.036

10.  Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants.

Authors:  Damayanthi Devineni; Nicole Vaccaro; Joe Murphy; Christopher Curtin; Rao N V S Mamidi; Sveta Weiner; Shean-Sheng Wang; Jay Ariyawansa; Hans Stieltjes; Ewa Wajs; Nicholas A Di Prospero; Paul Rothenberg
Journal:  Int J Clin Pharmacol Ther       Date:  2015-02       Impact factor: 1.366

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.